CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
CME's 62% net margin towers over Morningstar's 15.3%, but valuation metrics tell a different story for 2026 investors.
Overview
Investors often face a choice between high-profit infrastructure and data-driven growth when evaluating the market today. Choosing between CME Group (NASDAQ:CME) and Morningstar (NASDAQ:MORN) requires understanding how their respective business models generate cash.
CME dominates the global marketplace for futures and options, essentially serving as the toll booth for financial risk management. Morningstar provides the essential research and ratings that guide millions of investment decisions. They are being compared because both are critical players in the infrastructure of modern finance.
Details
CME Group operates the world's leading derivatives marketplace within the financial stocks sector, where participants trade futures and options on various assets. In its latest annual report, filed for the period ending in 2025, the company noted that 85% of its volume comes from its exchange members. Its customer base includes global banks and professional trading firms, and it recently launched a prediction markets venture with Flutter Entertainment (NYSE:FLUT).
Source
Originally published at www.fool.com.